By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Isis Pharmaceuticals, Inc. 

Carlsbad Research Center
2292 Faraday Avenue
Carlsbad  California  92008-7208  U.S.A.
Phone: 760-931-9200 Fax: 760-603-4650



Company News
Isis Pharma (ISIS) Reports Financial Results And Highlights For First Quarter 2015 5/5/2015 10:08:09 AM
Bayer HealthCare (BAY) Licenses Investigational ISIS FXI(Rx) From Isis Pharma (ISIS) To Develop And Commercialize For The Prevention Of Thrombosis 5/4/2015 8:57:41 AM
Isis Pharma (ISIS) Inks $155 Million Bayer (BAY) Deal Just After Good News From Biogen (BIIB) Collaboration 5/4/2015 7:15:11 AM
Isis Pharmaceuticals, Inc. (ISIS) Earns $10 Million Milestone Payment From Biogen (BIIB) 5/1/2015 7:44:25 AM
Webcast Alert: Isis Pharmaceuticals, Inc. (ISIS)' First Quarter 2015 Financial Results Conference Call 4/29/2015 11:40:33 AM
Isis Pharmaceuticals, Inc. (ISIS) Reports Positive Data From ISIS-TTR Rx In Patients With TTR Amyloidosis 4/23/2015 10:59:11 AM
Isis Pharmaceuticals, Inc. (ISIS) To Present At Upcoming Investor Conferences 4/10/2015 11:12:42 AM
Isis Pharmaceuticals, Inc. (ISIS) Reports Positive Phase 1 Data on Isis-ANGPTL3Rx 3/23/2015 6:35:58 AM
Interleukin Genetics Inc. (ILGN) Expands Its Collaboration With Isis Pharmaceuticals, Inc. (ISIS) For Genetic Testing Services 3/9/2015 10:24:22 AM
Isis Pharmaceuticals, Inc. (ISIS) Earns $9 Million For Advancing ISIS-SMN Rx In Infants With Spinal Muscular Atrophy 3/6/2015 6:46:48 AM